Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has a beta value of 2.01 and has seen 1.49 million shares traded in the recent trading session. The company, currently valued at $79.01M, closed the recent trade at $14.13 per share which meant it gained $1.11 on the day or 8.54% during that session. The TNXP stock price is -8505.8% off its 52-week high price of $1216.00 and 52.16% above the 52-week low of $6.76.
The consensus among analysts is that Tonix Pharmaceuticals Holding Corp (TNXP) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 5 have rated it as a Hold, with 4 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Sporting 8.54% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TNXP stock price touched $14.13 or saw a rise of 24.15%. Year-to-date, Tonix Pharmaceuticals Holding Corp shares have moved -57.15%, while the 5-day performance has seen it change 91.49%. Over the past 30 days, the shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) have changed 25.73%.
Tonix Pharmaceuticals Holding Corp (TNXP) estimates and forecasts
The company’s shares have lost -11.01% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 66.71%.
2 analysts offering their estimates for the company have set an average revenue estimate of 3.35M for the current quarter. 1 have an estimated revenue figure of 4.2M for the next ending quarter. Year-ago sales stood 3.78M and 2.48M respectively for this quarter and the next, and analysts expect sales will shrink by -11.35% for the current quarter and 66.71% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 79.31% over the past 5 years. Earnings growth for 2025 is a modest 95.88% while over the next 5 years, the company’s earnings are expected to increase by 78.59%.
TNXP Dividends
Tonix Pharmaceuticals Holding Corp is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund. As of Dec 31, 2024, the former fund manager holds about 0.19% shares in the company for having 10.45 shares of worth $0.15 million while later fund manager owns 4.03 shares of worth $56865.0 as of Dec 31, 2024, which makes it owner of about 0.07% of company’s outstanding stock.
